Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90 CHF | +0.99% | +6.48% | +6.04% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
Sales 2024 * | 48.71B 44.5B | Sales 2025 * | 50.51B 46.14B | Capitalization | 199B 182B |
---|---|---|---|---|---|
Net income 2024 * | 10.23B 9.35B | Net income 2025 * | 11.85B 10.82B | EV / Sales 2024 * | 4.33 x |
Net Debt 2024 * | 12.19B 11.13B | Net Debt 2025 * | 10.72B 9.79B | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
16.7
x | Employees | 76,057 |
Yield 2024 * |
3.69% | Yield 2025 * |
3.83% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +0.99% | ||
1 week | +6.48% | ||
Current month | +3.01% | ||
1 month | +4.15% | ||
3 months | -2.96% | ||
6 months | +4.87% | ||
Current year | +6.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 18 M€ | +3.04% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 90 | +0.99% | 4 555 418 |
24-04-24 | 89.12 | +0.20% | 3,572,943 |
24-04-23 | 88.94 | +1.81% | 8,288,764 |
24-04-22 | 87.36 | +2.14% | 4,375,338 |
24-04-19 | 85.53 | +1.19% | 3,719,061 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.04% | 199B | |
+24.17% | 562B | |
-6.44% | 358B | |
+19.18% | 322B | |
+7.64% | 297B | |
+13.45% | 219B | |
-10.51% | 196B | |
-11.32% | 149B | |
-6.79% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- NOVN Stock